Outcome of domino hematopoietic stem cell transplantation in human subjects: An international case series

Inborn Errors Working Party of the European Group for Blood and Marrow Transplantation and the Primary Immune Deficiency Treatment Consortium

doi:10.1016/j.jaci.2018.06.030

Outcome of domino hematopoietic stem cell transplantation in human subjects: An international case series

Inborn Errors Working Party of the European Group for Blood and Marrow Transplantation and the Primary Immune Deficiency Treatment Consortium

Group Belderbos

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	1628-1631.e4
Journal	Journal of Allergy and Clinical Immunology
Volume	142
Issue number	5
DOIs	https://doi.org/10.1016/j.jaci.2018.06.030
Publication status	Published - Nov 2018

Access to Document

10.1016/j.jaci.2018.06.030

Cite this

@article{82a47cb239f24aea81026921dde9a4d9,

title = "Outcome of domino hematopoietic stem cell transplantation in human subjects: An international case series",

author = "{Inborn Errors Working Party of the European Group for Blood and Marrow Transplantation and the Primary Immune Deficiency Treatment Consortium} and Belderbos, {Mirjam E.} and Gennery, {Andrew R.} and Dvorak, {Christopher C.} and Blok, {Henric Jan} and Eikema, {Dirk Jan} and Silva, {Juliana M.F.} and Paul Veys and B{\'e}n{\'e}dicte Neven and Rebecca Buckley and Theresa Cole and Cowan, {Morton J.} and Goebel, {W. Scott} and Manfred Hoenig and Kuo, {Caroline Y.} and Stiehm, {E. Richard} and Robert Wynn and Marc Bierings",

note = "Funding Information: The Primary Immune Deficiency Treatment Consortium is supported by the Division of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Diseases (NIAID), and the Office of Rare Diseases Research (ORDR), National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Bethesda, MD, Public Health Service grant/cooperative agreements U54-AI082973 (Principal Investigator: M.J.C.). The content and opinions expressed are solely the responsibility of the authors and do not represent the official policy or position of the NIAID, ORDR, NCATS, NIH, HRSA, or any other agency of the US Government. M.E.B. is financially supported by a Bas Mulder Award from the Dutch Cancer Society (grant no. RUG 2015-7964). ",

year = "2018",

month = nov,

doi = "10.1016/j.jaci.2018.06.030",

language = "English",

volume = "142",

pages = "1628--1631.e4",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier Inc.",

number = "5",

}

Inborn Errors Working Party of the European Group for Blood and Marrow Transplantation and the Primary Immune Deficiency Treatment Consortium 2018, 'Outcome of domino hematopoietic stem cell transplantation in human subjects: An international case series', Journal of Allergy and Clinical Immunology, vol. 142, no. 5, pp. 1628-1631.e4. https://doi.org/10.1016/j.jaci.2018.06.030

Outcome of domino hematopoietic stem cell transplantation in human subjects: An international case series. / Inborn Errors Working Party of the European Group for Blood and Marrow Transplantation and the Primary Immune Deficiency Treatment Consortium.
In: Journal of Allergy and Clinical Immunology, Vol. 142, No. 5, 11.2018, p. 1628-1631.e4.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Outcome of domino hematopoietic stem cell transplantation in human subjects

T2 - An international case series

AU - Inborn Errors Working Party of the European Group for Blood and Marrow Transplantation and the Primary Immune Deficiency Treatment Consortium

AU - Belderbos, Mirjam E.

AU - Gennery, Andrew R.

AU - Dvorak, Christopher C.

AU - Blok, Henric Jan

AU - Eikema, Dirk Jan

AU - Silva, Juliana M.F.

AU - Veys, Paul

AU - Neven, Bénédicte

AU - Buckley, Rebecca

AU - Cole, Theresa

AU - Cowan, Morton J.

AU - Goebel, W. Scott

AU - Hoenig, Manfred

AU - Kuo, Caroline Y.

AU - Stiehm, E. Richard

AU - Wynn, Robert

AU - Bierings, Marc

N1 - Funding Information: The Primary Immune Deficiency Treatment Consortium is supported by the Division of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Diseases (NIAID), and the Office of Rare Diseases Research (ORDR), National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Bethesda, MD, Public Health Service grant/cooperative agreements U54-AI082973 (Principal Investigator: M.J.C.). The content and opinions expressed are solely the responsibility of the authors and do not represent the official policy or position of the NIAID, ORDR, NCATS, NIH, HRSA, or any other agency of the US Government. M.E.B. is financially supported by a Bas Mulder Award from the Dutch Cancer Society (grant no. RUG 2015-7964).

PY - 2018/11

Y1 - 2018/11

UR - http://www.scopus.com/inward/record.url?scp=85050653464&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2018.06.030

DO - 10.1016/j.jaci.2018.06.030

M3 - Article

C2 - 29981805

AN - SCOPUS:85050653464

SN - 0091-6749

VL - 142

SP - 1628-1631.e4

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 5

ER -